KW is all talk. Continuos promises .
Likes reps that kiss his ass verses reps that are actually hitting their numbers .
Likes reps that kiss his ass verses reps that are actually hitting their numbers .
a really big contract win for AMAG, West Coast major account and we will be making announcements soon, AMAG rules!
big for amag or big for DSI
our cogs are greater than your total revenue. Small little company that hires rejects. Just wait and see
AMAG Cash 328.71M
DSI cash 2.7B
----------
AMAG market cap 823.84M
DSI market cap 22.12B
DSI could buy AMAG and still have 1.9B leftover to cover all the lawsuits on your multi "boxed" product line.
----------
AMAG profit margin -32.66%
DSI profit margin 3.94%
'yup you guys are killing it
----------
AMAG revenue 609.95M
DSI revenue 8.99B
wow... is that over 8 times the revenue. Fantastic Company
----------
AMAG return on equity -23.10%
DSI return on equity 2.66%
return on equity is a measure of how well a company uses investments to generate earnings growth. So is negative a good thing or a bad thing.
----------
DSI cash 2.7B
----------
AMAG market cap 823.84M
DSI market cap 22.12B
DSI could buy AMAG and still have 1.9B leftover to cover all the lawsuits on your multi "boxed" product line.
----------
AMAG profit margin -32.66%
DSI profit margin 3.94%
'yup you guys are killing it
----------
AMAG revenue 609.95M
DSI revenue 8.99B
wow... is that over 8 times the revenue. Fantastic Company
----------
AMAG return on equity -23.10%
DSI return on equity 2.66%
return on equity is a measure of how well a company uses investments to generate earnings growth. So is negative a good thing or a bad thing.
----------
AMAG gross profit 426.78M
DSI gross profit 605.75B
**remind me what was AMAG's market cap** with one quarters gross profit we could buy your company and have money left over to pay the severance to all the DSI r*****s that you hired.
----------
That's exactly how AMAG is crushing DSI
You run your mouth like your company runs its clinical studies.
Can't ignore the facts, can't ignore the results, and can't ignore that we are a global enterprise that has the talent and resources to break into the ONC/Rare Disease marketplace.
DSI gross profit 605.75B
**remind me what was AMAG's market cap** with one quarters gross profit we could buy your company and have money left over to pay the severance to all the DSI r*****s that you hired.
----------
That's exactly how AMAG is crushing DSI
You run your mouth like your company runs its clinical studies.
Can't ignore the facts, can't ignore the results, and can't ignore that we are a global enterprise that has the talent and resources to break into the ONC/Rare Disease marketplace.
I believe in God, I just don't believe in organized religion.
Amen. Perfect post to shutdown the BK and LS. Why on earth are they trying to sabotage the company they work for.
no see where you are in 6 months, it will be the unemployment line, they’ll cut your sales force by at least half. you’re all in big big trouble!
keith was bag at AMAG interviewing just before heading out for your gold cup
Yes Florida, CCare and North Shore bit they aren’t flipping until September so a few months before it will hit but it will kill our chances of making number a and making bonus too and it doesn’t look like we have anything to fight back with other than price and AES are coming up all of the time now too
Lost Big contracts and no chance in that changing anytime soon. Finally starting a new position in real oncology and leaving this shithole...
Wake up folks.
U won’t be selling it anyway at DSI. Get out while U can or keep drinking the juice.
Wake up folks.
U won’t be selling it anyway at DSI. Get out while U can or keep drinking the juice.
The oncology community is really worked up about the severe hypophosphatemia in the AMAG trial. I'm seeing accounts starting to flip just because of this! Multiple lawsuits on the way, my friends. And AMAG about to release their copay card program. We are doomed, folks.
this company just sold off the cord registry division and we are making a generic version of the top producing product. what is the fate of this company